ESRX - Express Scripts Holding Company

NasdaqGS - NasdaqGS Real-time price. Currency in USD
61.575
+0.155 (+0.252%)
As of 1:56PM EST. Market open.
Stock chart is not supported by your current browser
Previous close61.420
Open61.580
Bid61.540 x 200
Ask61.560 x 400
Day's range60.930 - 61.620
52-week range55.800 - 77.500
Volume939,592
Avg. volume3,650,295
Market cap35.56B
Beta0.97
PE ratio (TTM)10.69
EPS (TTM)5.762
Earnings date12 Feb 2018 - 16 Feb 2018
Forward dividend & yield0.00 (0.00%)
Ex-dividend date2003-11-12
1y target est67.64
Trade prices are not sourced from all markets
  • Barrons.com6 days ago

    [$$] Two Lawsuits Hit Express Scripts Unit on Pricing

    A securities filing made Tuesday by Express Scripts Holdings (ESRX) disclosed two large lawsuits that claim its subsidiary United Biosource helped drugmakers market their products in violation of antitrust and anti-kickback laws. The allegations in those suits touch on issues that Barron’s covered in a 2015 story that described how UBC’s contracts to promote drugmakers’ high-priced products seemed to conflict with the mission of its pharmacy benefit management parent: that is, to keep a lid on America’s drug bills (“Express Scripts Unit’s Connection to High Priced Specialty Drugs,” November 21, 2015). Other companies also named as defendants in the two suits were Eli Lilly & Co. (LLY) and Mallinckrodt PLC (MNK), as well as the Covance unit of Laboratory Corp. of America Holdings (LH).

  • Express Scripts signs a deal with start-up Propeller Health as it ups investment in digital health
    CNBC6 days ago

    Express Scripts signs a deal with start-up Propeller Health as it ups investment in digital health

    Express Scripts, the largest pharmacy benefits manager, is teaming up with a start-up that specializes in COPD and asthma.

  • Forbes8 days ago

    Neal Sample's Journey From CIO To Divisional President At Amex To CIO Of Express Scripts

    Express Scripts CIO Neal Sample has extraordinary breadth and depth of experience. He has a PhD in computer science from Stanford, and can dig deep into the technical weeds, has run businesses in addition to being a CIO, and has worked for digital natives (Yahoo and eBay) and behemoths alike.

  • Amazon should buy these companies if it wants to get into selling drugs
    CNBC19 days ago

    Amazon should buy these companies if it wants to get into selling drugs

    Amazon is considering getting into selling pharmaceuticals.

  • Amazon may indeed be getting into the pharma space -- but recent state license deals are not related
    CNBC21 days ago

    Amazon may indeed be getting into the pharma space -- but recent state license deals are not related

    Amazon is laying the groundwork for a move into health, says drug supply chain expert Stephen Buck. But not necessarily into pharmacy, at least not yet.

  • MarketWatch21 days ago

    CVS-Aetna deal won’t necessarily make drugs cheaper — and could even raise prices

    Savings on medical and pharmacy costs are a major aspect of the deal, but this Wall Street analyst doesn’t see it happening.

  • Express Scripts (ESRX) in Focus: Stock Moves 5.5% Higher
    Zacks22 days ago

    Express Scripts (ESRX) in Focus: Stock Moves 5.5% Higher

    Express Scripts (ESRX) saw its shares rise over 5% on the day.

  • Reuters23 days ago

    CVS bid for Aetna: A $66 billion bet on cutting drug costs

    The proposed merger between U.S. pharmacy operator CVS Health Corp and No. 3 health insurer Aetna Inc represents a $66 billion bet that insurers can drive down high U.S. drug prices by cutting out the middleman. The move is the most expensive effort to date that would enable a national health insurer to take back full control of prescription medicines for their customers by negotiating prices with pharmaceutical manufacturers and setting customer out-of-pocket costs for each drug. CVS, one of the largest U.S. pharmacy benefits managers, has offered to buy No. 3 health insurer Aetna for more than $200 per share, sources said on Thursday.

  • CVS-Aetna Deal Could Mean End of Era in How Drugs Are Paid For
    Bloomberg25 days ago

    CVS-Aetna Deal Could Mean End of Era in How Drugs Are Paid For

    The potential acquisition of Aetna Inc. by CVS Health Corp. would create an integrated health-care behemoth and put huge pressure on standalone players such as Express Scripts Holding Co. and Walgreens ...

  • Barrons.com25 days ago

    [$$] Express Scripts Buy Looks Healthy

    Maxim Group We would continue to be buyers of Express Scripts following its conference call on mixed third-quarter results. Express Scripts (ESRX) provided additional detail on the pending acquisition of eviCore and on its previously announced enterprise value initiative.

  • Reuters26 days ago

    Amazon gains wholesale pharmacy licenses in many U.S. states: report

    (Reuters) - Amazon.com Inc (AMZN.O) has gained approval from a number of state pharmaceutical boards to become a wholesale distributor, St. Louis Post-Dispatch reported on Thursday, citing public records. ...

  • Express Scripts (ESRX) Q3 2017 Earnings Conference Call Transcript
    Motley Fool26 days ago

    Express Scripts (ESRX) Q3 2017 Earnings Conference Call Transcript

    ESRX earnings call for the period ending September 30, 2017.

  • The Wall Street Journal27 days ago

    [$$] Express Scripts Only Looks Cheap

    The pharmacy-benefits manager has a low valuation but that masks challenges including growth, regulation and competition.

  • Reuters27 days ago

    Express Scripts shrugs off Amazon threat in pharmacy benefits

    Express Scripts, the biggest pharmacy benefit manager (PBM)in the United States, along with drug distributors have been under pressure by the rumored entry of Amazon into the prescription drug market. "I feel very confident we'll stand well against an entry in the PBM space, be it Amazon or anybody," Express Scripts Chief Executive Timothy Wentworth said on a conference call. Express Scripts, which reported lower-than-expected quarterly revenue on Tuesday, named James Havel as the chief financial officer and said it aims to retain more customers in 2018.

  • Reuters27 days ago

    Express Scripts shrugs off Amazon threat in pharmacy benefits

    Express Scripts, the biggest pharmacy benefit manager (PBM)in the United States, along with drug distributors have been under pressure by the rumored entry of Amazon into the prescription drug market. "I feel very confident we'll stand well against an entry in the PBM space, be it Amazon or anybody," Express Scripts Chief Executive Timothy Wentworth said on a conference call. Express Scripts, which reported lower-than-expected quarterly revenue on Tuesday, named James Havel as the chief financial officer and said it aims to retain more customers in 2018.

  • MarketWatch27 days ago

    3 reasons Express Scripts could be headed for trouble

    Threatened by Amazon and having lost its biggest client, Express Scripts stock has dropped nearly 18% in three months.

  • Express Scripts (ESRX) Q3 Earnings In Line, FY17 View Up
    Zacks27 days ago

    Express Scripts (ESRX) Q3 Earnings In Line, FY17 View Up

    Express Scripts Holding Company (ESRX) posted robust first-quarter numbers driven by operational cost improvement backed by focus on technology, digital tools, home delivery and specialty services.

  • Reuters28 days ago

    Express Scripts CFO Eric Slusser resigns

    (Reuters) - Express Scripts Holding Co (ESRX.O) said on Tuesday James Havel would succeed Eric Slusser as the chief financial officer, effective Oct. 25, and the pharmacy benefit manager aimed to retain ...

  • The Wall Street Journal28 days ago

    [$$] Express Scripts Names Havel as Finance Chief

    Pharmacy-benefit manager Express Scripts Holding Co. has named veteran finance executive James Havel to serve as its finance chief, returning him to a role he held on an interim basis two years ago.

  • Associated Press28 days ago

    Express Scripts meets 3Q profit forecasts

    The St. Louis-based company said it had profit of $1.46 per share. Earnings, adjusted for one-time gains and costs, were $1.90 per share. The results met Wall Street expectations. The average estimate ...

  • Will CNC Q3 Earnings Come in Better Than ESRX on Oct 24?
    Zacks29 days ago

    Will CNC Q3 Earnings Come in Better Than ESRX on Oct 24?

    Centene (CNC) is expected to post better results in Q3 compared to Express Scripts (ESRX) on the back of solid revenue growth driven by rising membership.

  • MarketWatchlast month

    Anthem dumps Express Scripts in favor of starting its own pharmacy-benefit manager

    Anthem’s entry is notable in a highly concentrated industry dominated by just a few large players.

  • Forbeslast month

    Why Drug Makers Should Worry About Anthem's New PBM

    Insurers are closing ranks around a model that brings the PBM closer to the health plan in hopes of creating a savvier buyer of prescription medicines while seeking more transparency.

  • The Wall Street Journallast month

    [$$] Anthem to Launch Its Own Pharmacy-Benefit Manager

    Anthem plans to launch its own pharmacy-benefit manager, serviced by CVS Health, in 2020 after the conclusion of its contract with Express Scripts.

  • The Wall Street Journallast month

    [$$] Investors Need to Watch This Nasty Drug-Price Feud

    Pharmacy-benefit managers are supposed to reduce drug prices but haven’t, and their customers are pushing back.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes